Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06626022 · ClinicalTrials.gov registry record · Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
A Phase 3 study of Prostate Cancer Screening, sponsored by University of Alberta.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 1,284
- Enrollment target
- 5
- Study locations
NCT06626022 is a Phase 3 study of Prostate Cancer Screening that is actively recruiting participants, run by University of Alberta. The registered enrollment target is 1,284 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT06626022, a Phase 3 study of Prostate Cancer Screening, is actively recruiting participants, sponsored by University of Alberta.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 1,284 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new microUS. The study is looking to identify the most effective imaging modality to help guide whether you progress to have a prostate biopsy.
Conditions Studied
Interventions
- DEVICE MRI
- DEVICE ExactVu
Study Locations (5)
California
- University of California, Los Angeles (UCLA) - Los Angeles
Alberta
- University of Alberta - Edmonton
British Columbia
- University of British Columbia - Vancouver
Quebec
- CIUSSS du Nord-de-l'Île-de-Montréal - Montréal
Other
- Urologia Clinica Bilbao - Bilbao
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,284 participants |
| Start Date | 2025-05-08 |
| Est. Completion | 2029-11-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06626022
The ClinicalTrials.gov registry entry for NCT06626022 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 1,284 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alberta, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer Screening appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.
NCT06626022 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Alberta, British Columbia.
Frequently Asked Questions
What is clinical trial NCT06626022 about?
NCT06626022 is a clinical study titled "Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.". The purpose of this study is to compare whether the FDA and Health Canada approved microUS is as effective as the currently used option (MRI) for imaging the prostate gland. Participants will be randomized into two groups to compare the imaging results of the current standard of care MRI and the new...
What is the current status of trial NCT06626022?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 1,284 participants. The study started on 2025-05-08. Estimated completion is 2029-11-30.
What conditions does trial NCT06626022 study?
This clinical trial studies the following conditions: Prostate Cancer Screening.
What interventions are being tested in trial NCT06626022?
The interventions under investigation include: MRI (DEVICE), ExactVu (DEVICE).
Who is sponsoring clinical trial NCT06626022?
This trial is sponsored by University of Alberta, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06626022 being conducted?
This trial has 5 study locations across California, Alberta, British Columbia, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer Screening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.